Rich Meelia , MBA

Mansfield, MA

Richard J. Meelia is Chairman, President, Chief Executive Officer and a Director of Covidien Ltd., a leading $10 billion global healthcare products company. The business, formerly known as Tyco Healthcare, spun off from parent company Tyco International on June 29, 2007.

Covidien manufactures, distributes and services a diverse range of medical devices, supplies, imaging products and pharmaceuticals, sold under industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture, United States Surgical, Valleylab and others. Covidien has more than 43,000 employees in 57 countries, and its products are sold in over 130 countries.

Mr. Meelia, 60, joined Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, as Group President in 1991 and became President of Tyco Healthcare in 1995. During the ensuing decade, he directed Tyco Healthcare?s acquisition, integration and product development efforts, growing the business from $600 million to the diverse $10 billion healthcare products leader it is today.

Prior to joining Kendall/Tyco Healthcare, Mr. Meelia was President of Infusaid, Inc., a division of Pfizer Hospital Products Group that manufactures and markets implantable infusion pumps and ports. Before that, he held sales and marketing positions with the Pharmaseal and McGaw divisions of the American Hospital Supply Corporation.

A graduate of Saint Anselm College, Mr. Meelia earned an MBA degree from Boston College.

Mr. Meelia is a member of the Board of Directors of Triangle, a career empowerment network for people with disabilities, and the Board of Directors of Massachusetts Hospital School. He serves on the Board of Governors of the Tufts Medical Center and the Board of Trustees of St. Anselm College.

Contact Information

15 Hampshire Street
Mansfield, MA 02048


Research Interests